Abstract
We report the case of a 75-year old woman who received sorafenib (Nexavar), Bayer Pharmaceuticals Corporation, West Haven, CT) for a CNS relapse of clear cell renal cell carcinoma. After four months of sorafenib treatment, a brain magnetic resonance imaging showed 95%-volumetric regression of cerebral metastasis. To the best of our knowledge, this is the first almost complete resolution of brain metastases in renal cell carcinoma treated with sorafenib that has been described.
References
Sep 19, 1996·The New England Journal of Medicine·R J MotzerD M Nanus
Jan 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerMadhu Mazumdar
Feb 10, 2004·The Journal of Urology·Robert C FlaniganE David Crawford
Oct 7, 2004·Cancer Research·Scott M WilhelmPamela A Trail
Apr 8, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C MassardJ-C Soria
Apr 26, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark J RatainPeter J O'Dwyer
Nov 28, 2006·European Urology·Quoc-Dien TrinhPierre I Karakiewicz
Jan 12, 2007·The New England Journal of Medicine·Bernard EscudierUNKNOWN TARGET Study Group
May 2, 2007·The Oncologist·Dirk StrumbergBrian Schwartz
Jun 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elizabeth R Gerstner, Robert L Fine
Sep 27, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S BracardaL Crinò
Aug 7, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J MedioniS Oudard
Jan 1, 2008·The Oncologist·Luciano J Costa, Harry A Drabkin
Citations
Oct 16, 2009·Expert Review of Anticancer Therapy·Axel S MerseburgerMarkus A Kuczyk
Sep 8, 2010·BMC Cancer·Ursula M VoglManuela Schmidinger
May 11, 2017·Journal of Neuro-oncology·Kyle ArnesonFen Xia
Jul 22, 2017·Tumori·Ibrahim YildizMert Basaran
Nov 17, 2010·BJU International·Joaquim BellmuntCamillo Porta
Nov 13, 2010·Investigational New Drugs·AeRang KimBrigitte C Widemann
Nov 14, 2015·CNS Drugs·Michael P GabayJohn L Villano
Aug 19, 2011·Journal of Clinical Immunology·Oliver CrespoWilliam H Robinson
May 3, 2011·Expert Opinion on Investigational Drugs·Raffaele Addeo, Michele Caraglia
Jul 14, 2010·Targeted Oncology·Astrid A M van der VeldtEpie Boven
Apr 21, 2010·Journal of Neuro-oncology·Takashi ShutoHideyo Fujino
Sep 24, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shuiying HuSharyn D Baker
Jan 28, 2010·Molecular Cancer Therapeutics·Jurjen S LagasAlfred H Schinkel